If you need more lookups,
subscriptions start at $34 USD/month.
Mathis Thoma Location
Belmont, MA, US
Mathis Thoma Work
2021 -now Director Biostatistics @
2018 -2019 Head Biometrics and Data Management @
2015 -2018 Director @
2011 -2014 Associate Director @
2008 -2010 Executive Director, Prgram on Quantitative Sciences in Medicine @
2007 -2008 Consultant @
2004 -2007 Global Head Research Statistics @
2001 -2004 Global Head Research Statistics @ Novartis Pharmaceuticals Corporation Research Department
2000 -2001 Acting Site Head, Research Information Management @ Novartis Pharmaceuticals Coporation Research Department
1998 -2000 Director, Global Head High Performance Computing @ Novartis Pharmaceuticals Corporation Research Department
1997 -1998 US Head Scientific Computing @ Novartis Pharmaceuticals Corporation Research Department
1990 -1996 Associate Director, Research Statistics Services @
1988 -1990 Head, New System Development @ BMDP Statistical Software
Mathis Thoma Education
Eidgenössische Technische Hochschule Zürich
Master Of Science (Mathematics)
Harvard University
Doctor Of Philosophy (Statistics)
Mathis Thoma Skills
Research
Biostatistics
Project Management
Drug Discovery
Lifesciences
Statistics
Clinical Trials
Pharmaceutical Industry
Biotechnology
Life Sciences
Data Analysis
Clinical Development
Molecular Biology
Biochemistry
Drug Development
Oncology
Clinical Research
Clinical Pharmacology
Mathis Thoma Summary
Mathis Thoma, based in Belmont, MA, US, is currently a Director Biostatistics at Leap Therapeutics, Inc.. Mathis Thoma brings experience from previous roles at Erytech Pharma, Teva Pharmaceuticals, Novartis and Harvard t.h. Chan School of Public Health. Mathis Thoma holds a Master Of Science in Mathematics @ Eidgenössische Technische Hochschule Zürich. With a robust skill set that includes Research, Biostatistics, Project Management, Drug Discovery, Lifesciences and more. Mathis Thoma has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mathis Thoma?
Find contact details for 700 million professionals.